Claim Details
View detailed information about this claim and its related sources.
Claim Information
Complete details about this extracted claim.
- Claim Text
-
The neuroscience team at Bristol Myers Squibb is focused on neurological conditions for which there are currently limited options — such as Alzheimer’s disease, autism spectrum disorder, bipolar disorder, multiple sclerosis and schizophrenia — and advancing research of new approaches that may modify the disease or alleviate symptoms.
- Simplified Text
-
Bristol Myers Squibb neuroscience team focuses on neurological conditions with limited options advancing research
- Confidence Score
- 0.500
- Claim Maker
- The author
- Context Type
- Website Article
- Context Details
-
{ "date": null } - Subject Tags
- UUID
- 9fc8a1be-d564-4b67-b17d-bf3cbfcbe9a1
- Vector Index
- ✗ No vector
- Created
- September 2, 2025 at 7:15 PM (1 week ago)
- Last Updated
- September 2, 2025 at 7:15 PM (1 week ago)
Original Sources for this Claim (1)
All source submissions that originally contained this claim.
37
claims
🔥
1 week ago
https://www.bms.com/life-and-science/science/renaissance-neuroscience-research-development.html?cid=d_3267515&dclid=CN-sjNPAsI8DFazArQAd_vguSA&gad_source=7
Bristol Myers Squibb is accelerating neuroscience R&D using breakthroughs in human biology, biomarkers, and computational science to improve outcomes for patients with neurological conditions. The company is exploring new approaches to slow disease progression and alleviate symptoms.
Similar Claims (0)
Other claims identified as semantically similar to this one.
No similar claims found
This claim appears to be unique in the system.